Correlation between the severity of coronary artery lesions and levels of estrogen, hs-CRP and MMP-9

Experimental and Therapeutic Medicine

Volumn 7, Issue 5, 2014, Pages 1177-1180

  Guo, Changlei ^a   Zhang, Shaoli ^a   Zhang, Junbiao ^a   Liu, Hui ^a   Li, Peicheng ^a   Liu, Hengdao ^a   Wang, Yakun ^a  

^a Department of Burn and Plastic Surgery   (China)

Author keywords

Acute coronary syndrome; Estrogen; High sensitivity C reactive protein; Matrix metalloproteinase 9

Indexed keywords

C REACTIVE PROTEIN; ESTROGEN; GELATINASE B;

ACUTE CORONARY SYNDROME; ACUTE HEART INFARCTION; ADULT; AGED; ARTERY LESION; ARTICLE; BLOOD SAMPLING; CONTROLLED STUDY; CORONARY ARTERY; CORRELATION ANALYSIS; DISEASE SEVERITY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; STABLE ANGINA PECTORIS;

EID: 84896892039     PISSN: 17920981     EISSN: 17921015     Source Type: Journal    
DOI: 10.3892/etm.2014.1565     Document Type: Article

References (19)

1. Harutyunyan M, Gøtze JP, Winkel P, et al: Serum YKL-40 predicts long-term mortality in patients with stable coronary disease: a prognostic study within the CLARICOR trial. Immunobiology 218: 945-951, 2013.
2. Falcone C, Lucibello S, Mazzucchelli I, et al: Galectin-3 plasma levels and coronary artery disease: a new possible biomarker of acute coronary syndrome. Int J Immunopathol Pharmacol24: 905-913, 2011.
3. Sakamoto Y, Muramatsu T, Tsukahara R, Ito Y, Ishimori H, Hirano K and Nakano M: A case achieved successful revascularization to severe ischemic coronary artery disease after endovascular recanalization with infrarenal aortic occlusion. Cardiovasc Interv Ther 27: 93-98, 2012.
4. Oh JE, Kim YW, Park SY and Kim JY: Estrogen rather than progesterone cause constipation in both female and male mice. Korean J Physiol Pharmacol 17: 423-426, 2013.
5. Seo SM, Baek SH, Jeon HK, et al: Correlations between the level of high-sensitivity c-reactive protein and cardiovascular risk factors in korean adults with cardiovascular disease or diabetes mellitus: the CALLISTO study. J Atheroscler Thromb 20: 616-622, 2013.
6. Yabluchanskiy A, Ma Y, Iyer RP, Hall ME and Lindsey ML: Matrix metalloproteinase-9: Many shades of function in cardiovascular disease. Physiology (Bethesda) 28: 391-403, 2013.
7. Duellman T, Warren CL, Peissig P, Wynn M and Yang J: Matrix metalloproteinase-9 genotype as a potential genetic marker for abdominal aortic aneurysm. Circ Cardiovasc Genet 5: 529-537, 2012.
8. Miller VM, Petterson TM, Jeavons EN, et al: Genetic polymorphisms associated with carotid artery intima-media thickness and coronary artery calcification in women of the Kronos Early Estrogen Prevention Study. Physiol Genomics 45: 79-88, 2013.
9. Rashidinejad H, Hosseini SM, Moazenzadeh M, Azimzadeh BS, Mirzaeipour F, Fakhreddini K and Sheikhvatan M: Relationship between serum level of high-sensitive C-reactive protein and extension of myocardial involvement in patients with acute myocardial infarction. Rom J Intern Med 50: 211-215, 2012.
10. Golovkin AS, Matveeva VG, Grigor'ev EV, Baǐrakova IuV, Shukevich DL, Velikanova EA and Barbarash OL: Postoperative dynamic changes in matrix metalloproteinase levels in patients with coronary artery bypass graft procedure complications. Kardiologiia 52: 4-7, 2012 (In Russian).
11. Salama MM, Morad AR, Saleh MA, Sabri NA, Zaki MM and ElSafady LA: Resistance to low-dose aspirin therapy among patients with acute coronary syndrome in relation to associated risk factors. J Clin Pharm Ther 37: 630-636, 2012.
12. Kehl DW, Iqbal N, Fard A, Kipper BA, De La Parra Landa A and Maisel AS: Biomarkers in acute myocardial injury. Transl Res159: 252-264, 2012.
13. Cristell N, Cianflone D, Durante A, et al: High-sensitivity C-reactive protein is within normal levels at the very onset of first ST-segment elevation acute myocardial infarction in 41% of cases: a multiethnic case-control study. J Am Coll Cardiol 58: 2654-2661, 2011.
14. Akhtar N, Adil MM, Ahmed W, Habib-ur-Rehman and ShahsMA: The role of leukocyte counts in patients with unstable angina pectoris or myocardial infarction; prognostic significance and correlation with plasma brain natriuretic peptide (BNP) levels. J Pak Med Assoc 61: 51-54, 2011.
15. Huang G, Wang D, Zeb I, et al: Intra-thoracic fat, cardiometabolic risk factors, and subclinical cardiovascular disease in healthy, recently menopausal women screened for the Kronos Early Estrogen Prevention Study (KEEPS). Atherosclerosis 221: 198-205, 2012.
16. Mirhosseini SJ, Forouzannia SK, Ali-Hassan-Sayegh S, RavanHV, Abdollahi MH and Mozayan MR: Preoperative C-reactive protein can predict early clinical outcomes following elective off-pump CABG surgery in patients with severe left ventricle dysfunction. Saudi J Anaesth 6: 327-331, 2012.
17. Crǎciunescu I, Serban M, Iancu M, et al: Changes in plasma levels of MMP-9, MMP-7 and their inhibitors in patients with coronary artery disease. Rom J Intern Med 48: 141-149, 2010.
18. Park JP, Lee BK, Shim JM, Kim SH, Lee CW, Kang DH and Hong MK: Relationship between multiple plasma biomarkers and vulnerable plaque determined by virtual histology intravascular ultrasound. Circ J 74: 332-336, 2010.
19. Datta S, Iqbal Z and Prasad KR: Comparison between serum hsCRP and LDL cholesterol for search of a better predictor for ischemic heart disease. Indian J Clin Biochem 26: 210-213, 2011.